The NYS Attorney General’s office requests that all patients, their doctors, or their representatives make a call to Health Care Bureau’s toll-free Helpline or fill out a complaint form if they feel they have been wrongly denied coverage for their hepatitis treatment medications.
Call the Health Care Bureau’s toll-free Helpline to speak to patient advocate: 1-800-428-9071
or
Fill out the online complaint form
Last Updated on January 25, 2020 by HepFree NYC
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
Thanks to all from the Hepatitis Health Care Access, Insurance & Medications Workgroup who worked on this and took action!!! The vast discrepancy between Prior Authorization Forms utilized by Medicaid Managed Care plans was cited as a significant waste of time & energy ...
The Hepatitis A, B and C in NYC: 2021 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
NYS ADAP will be offering access to new Hep C meds, including Zepatier, Viekira pak, Viekira XR, and Daklinza.
Ad Hoc Advocacy Committee Meeting Wednesday, July 14 (3-4 pm) Agenda: Viral Hepatitis Initiative – City Council Funding FY2022 https://council.nyc.gov/budget/wp-content/uploads/sites/54/2021/06/Fiscal-2022-Schedule-C-Merge-6.30.21.pdf Overall increase in funding lev...
The Hepatitis A, B and C in NYC: 2022 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
The NYS Department of Health’s, AIDS Institute is hosting a series of community calls to allow an opportunity for comments and feedback on the completed preliminary recommendations for hepatitis C elimination in NYS and now we need your input!
